BSEInsider Trading / SAST19 Oct 2026 · 19 Oct 2026, 10:43 am

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Lenus Finvest Pvt Ltd

Eiko Lifesciences Ltd · 540204

✦ AI SummaryPledge

Eiko Lifesciences Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Lenus Finvest Private Ltd, a promoter group entity, regarding the conversion of 1,50,000 warrants into 1,50,000 equity shares, resulting in Lenus Finvest Private Ltd's holding of 1,50,000 equity shares, representing 1.02% of Eiko Lifesciences Ltd's issued and subscribed equity shares, and an aggregate holding of 26,90,472 equity shares, representing 18.18% of the total issued capital on a non-diluted basis.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern6/10
Regulatory Risk8/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Attachments (1)

📄

D1EAC316_03CE_4DF4_A686_0AFC31056149_104258.pdf

pdf

Download →
View document text
LENUS FINVEST PRIVATE LIMITED Phone: +91 93201 71272 | Email: lenusfinvest@gmail.com Date: 18™ October 2026 Corporate Services Department, Compliance Officer, BSE Limited, Eiko Lifesciences Limited, P J Towers, 1st Floor, Dalal Street, 604, Centrum, Opp TMC Office, Fort, Mumbai - 400001. Near Satkar Grande Hotel, Wagle Estate, Thane-400604 Scrip Code: 540204 Sub: Submission of Disclosure under Regulation 29(2) of Substantial Acquisition of Shares and Takeovers) Regulations, 2011 This is to inform you that on 16" October 2026, The Board of Directors of Eiko Lifesciences Ltd, allotted 1,50,000 Equity Shares pursuant to Conversion of 1,50,000 Warrants, issued on preferential basis to M/s Lenus Finvest Private Limited, Promoter Group Entity. Accordingly, we hereby inform you that M/s Lenus Finvest Private Limited, (part of Promoter Group of Eiko Lifesciences Ltd) has acquired 1,50,000 Equity Shares presenting 1.02% of the issued and subscribed Equity Shares of Eiko Lifesciences Limited. With the above-mentioned acquisition, our aggregate holding is 26,90,472 Equity Shares representing 18.18% of total Issued Capital on Non-Diluted Basis. Please find enclosed herewith the disclosure as required under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 2011. For Lenus Finvest Private Limited Siddhant Laxmikant Kabra Director DIN: 07470463 Encl: as above Registered Office: 604, Opp. TMC Office, near Satkar Grande hotel, Wagle estate, Thane, Maharashtra, India, 400604 CIN: U65923MH2015PTC270913 LENUS FINVEST PRIVATE LIMITED Phone: +91 93201 71272 | Email: lenusfinvest@gmail.com Format for disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Name of the Target Company (TC) Eiko Lifesciences Limited Name(s) of the acquirer and Persons Acting in Concert (PAC) with the Lenus Finvest Private Limited acquirer Yes~ Promoter group Whether the acquirer belongs to Promoter/Promoter group Name(s) of the Stock Exchange(s) where the shares of TCare Listed Bombay Stock Exchange (BSE Limited) % w.r.t. Total % w.r.t. total share/voting capital diluted Details of the acquisition/dispesal-as-fellows Number & 4 wherever applicable | share/voting capital )0 oftheTC(*) (**) Before the acquisition under consideration, holding of: a) Shares carrying voting rights 25,40,472 17.34% 14.69% b) Shares in the nature of encumbrance (pledge/ lien/ non- . . . disposal undertaking/ others) c) Voting rights (VR) otherwise than by shares - - - d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights 1,50,000 1.02% 0.87% in the TC (specify holding in each category) Total (a+b+c+d) 26,90,472 18.36% 15.56% Details of Acquisition/Sale a) Shares carrying voting rights acquired/sefe- 1,50,000 1.02% 0.87% b) Shares encumbered / invoked/released by the acquirer - - - ¢) VRs acquired /sold otherwise than by shares d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in - - - the TC (specify holding in each category) acquired/sold Total (a+b-c+d) 1,50,000 1.02% 0.87% After the acquisition/sale, holding of: a) Shares carrying voting rights 26,90,472 18.18% 15.56% b) Shares encumbered / invoked/released by the acquirer - - - ¢) VRs acquired /sold otherwise than by shares - - - d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in - - - the TC (specify holding in each category) acquired/sold Total (a+b+ct/-d) 26,90,472 18.18% 15.56% Mode of acquisition / sale (e.g. open market / off market/ public issue / rights issue / preferential allotment / inter-se Preferential Allotment*** transfer etc). Date of acquisition 16% October, 2026 Equity shares capital / total voting capital of the TC before the 14,65,08,540 said acquisition / sate (i.e. 1,46,50,854 Equity Shares of Rs. 10/- each) Registered Office: 604, Opp. TMC Office, near Satkar Grande hotel, Wagle estate, Thane, Maharashtra, India, 400604 CIN: U65923MH2015PTC270913 LENUS FINVEST PRIVATE LIMITED Phone: +91 93201 71272 | Email: lenusfinvest@gmail.com Equity share capital/ total voting capital of the TC after the 14,80,08,540 said acquisition /sale (i.e. 1,48,00,854 Equity Shares of Rs. 10/- each) Total diluted share/voting capital of the TC after the said 17,29,58,540 acquisition/sate (i.e. 1,72,95,854 Equity Shares of Rs. 10/- each) Note: (*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange. (**) We have adjusted the percentage w.r.t. total share/voting capital by 0.01 points. (***) 1,50,000 Warrants (convertible into Equity) were allotted on Preferential basis which are now being Converted into 1,50,000 Equity Shares. For Lenus Finvest Private Limited Siddhant Laxmikant Kabra Director DIN: 07470463 Registered Office: 604, Opp. TMC Office, near Satkar Grande hotel, Wagle estate, Thane, Maharashtra, India, 400604 CIN: U65923MH2015PTC270913